Search Media Items

Cancer Moonshot initiative to develop a better system for monitoring and managing patient-reported side effects, in an effort to minimize debilitating side effects and reduce cancer costs related to poorly controlled symptoms.

The development of cancer technologies to characterize tumors and test therapies can transform cancer research and clinical care.

This Cancer Moonshot initiative aims to establish a pediatric cancer immunotherapy network to discover and characterize new targets for immunotherapies and ultimately develop new, effective immunotherapy treatments for children and adolescents with cancer.

Researchers, clinicians, and patients across the country will need to share their collective data and knowledge to enable the development of new technologies and reduce the burden of cancer. This Cancer Moonshot initiative empowers and encourages such collaboration.

Frustration with the toxicities of chemotherapy and radiation spurs cancer survivor and investigator Greg Aune to look for less-toxic therapies for children.

Learn about the NCI-funded research that enabled the first FDA approved precision medicine- the immune checkpoint inhibitor pembrolizumab.

NCI’s strategic goals and priorities aim to direct progress against cancer to meet the needs of all people. Learn how priorities are set and how funding decisions are made at NCI.

A summary of TCGA's study of thymic epithelial cancer (thymoma), including what was known prior to the study and main findings from the characterization and analysis.

A summary of TCGA's study of uveal (intraocular or eye) melanoma, including what was known prior to the study and main findings from the characterization and analysis.

El virus del papiloma humano (VPH) es un grupo de más de 200 virus relacionados que pueden causar varios tipos de cáncer, incluyendo el cáncer de cuello uterino, el cáncer de ano y el cáncer de orofaringe. Obtenga más información sobre cómo se transmite el VPH, los diferentes tipos de VPH y las vacunas para prevenirlo.